Decreased serum LL-37 and vitamin D3 levels in atopic dermatitis: Relationship between IL-31 and oncostatin M

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 6, 2012, Pages 804-812

  Kanda, N ^a   Hau, C S ^b   Tada, Y ^b   Sato, S ^b   Watanabe, S ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

atopic dermatitis; IL 31; LL 37; oncostatin M; vitamin D3

Indexed keywords

CALCIFEDIOL; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD28 ANTIGEN; CD3 ANTIGEN; INTERLEUKIN 25; INTERLEUKIN 31; ONCOSTATIN M; PERTUSSIS TOXIN; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KERATINOCYTE; NEUTROPHIL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VITAMIN BLOOD LEVEL;

ANTIMICROBIAL CATIONIC PEPTIDES; CELLS, CULTURED; CHOLECALCIFEROL; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERLEUKINS; KERATINOCYTES; NEUTROPHILS; ONCOSTATIN M; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84861093789     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02824.x     Document Type: Article

References (32)

1. Guttman-Yassky E, Nograles KE, Krueger JG,. Contrasting pathogenesis of atopic dermatitis and psoriasis-Part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol 2011; 127: 1420-1432.
2. Schauber J, Gallo RL,. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2008; 122: 261-266.
3. Mrabet-Dahbi S, Maurer M,. Does allergy impair innate immunity? Leads and lessons from atopic dermatitis Allergy 2010; 65: 1351-1356.
4. Kanda N, Ishikawa T, Kamata M, Tada Y, Watanabe S,. Increased serum leucine, leucine-37 levels in psoriasis: positive and negative feedback loops of leucine, leucine-37 and pro- or anti-inflammatory cytokines. Hum Immunol 2010; 71: 1161-1171.
5. Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, et al. Antimicrobial peptides human b-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 2007; 27: 594-604.
6. Mallbris L, Carlén L, Wei T, Heilborn J, Nilsson MF, Granath F, et al. Injury downregulates the expression of the human cathelicidin protein hCAP18/LL-37 in atopic dermatitis. Exp Dermatol 2010; 19: 442-449.
7. Ballardini N, Johansson C, Lilja G, Lindh M, Linde Y, Scheynius A, et al. Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema. Br J Dermatol 2009; 161: 40-47.
8. Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, Udall D, et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 2008; 122: 829-831.
9. Benson AA, Toh JA, Vernon N, Jariwala SP,. The role of vitamin D in the immunopathogenesis of allergic skin diseases. Allergy 2012; 67: 296-301.
10. Javanbakht MH, Keshavarz SA, Djalali M, Siassi F, Eshraghian MR, Firooz A, et al. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J Dermatolog Treat 2011; 22: 144-150.
11. Bäck O, Blomquist HK, Hernell O, Stenberg B,. Does vitamin D intake during infancy promote the development of atopic allergy? Acta Derm Venereol 2009; 89: 28-32.
12. Colin EM, Asmawidjaja PS, van Hamburg JP, Mus AM, van Driel M, Hazes JM, et al. 1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 2010; 62: 132-142.
13. Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006; 116: 146-155.
14. Novak N, Simon D,. Atopic dermatitis-from new pathophysiologic insights to individualized therapy. Allergy 2011; 66: 830-839.
15. Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, Kikuchi T, et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009; 123: 1244-1252.
16. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, Yao L, et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006; 117: 418-425.
17. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5: 752-760.
18. Angkasekwinai P, Park H, Wang YH, Chang SH, Corry DB, Liu YJ, et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204: 1509-1517.
19. Hvid M, Vestergaard C, Kemp K, Christensen GB, Deleuran B, Deleuran M,. IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 2011; 131: 150-157.
20. Boniface K, Diveu C, Morel F, Pedretti N, Froger J, Ravon E, et al. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. J Immunol 2007; 178: 4615-4622.
21. Fritz DK, Kerr C, Fattouh R, Llop-Guevara A, Khan WI, Jordana M, et al. A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent. J Immunol 2011; 186: 1107-1118.
22. He R, Geha RS,. Thymic stromal lymphopoietin. Ann NY Acad Sci 2010; 118: 13-24.
23. Kanda N, Watanabe S,. Increased serum human β-defensin-2 levels in atopic dermatitis: relationship to IL-22 and oncostatin M. Immunobiology 2012; 217: 436-445.
24. Fölster-Holst R, Pape M, Buss YL, Christophers E, Weichenthal M,. Low prevalence of the intrinsic form of atopic dermatitis among adult patients. Allergy 2006; 61: 629-632.
25. Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A,. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997; 195: 10-19.
26. Searing DA, Leung DYM,. Vitamin D in atopic dermatitis, asthma and allergic diseases. Immunol Allergy Clin North Am 2010; 30: 397-409.
27. Cornelissen C, Lüscher-Firzlaff J, Baron JM, Lüscher B,. Signaling by IL-31 and functional consequences. Eur J Cell Biol 2011. doi: 10.1016/j.ejcb.2011.07.006. [Epub ahead of print].
28. Leung TF, Ching KW, Kong APS, Wong GWK, Chan JCN, Hon KL,. Circulating LL-37 is a biomarker for eczema severity in children. J Eur Acad Dermatol Venereol 2012; 26: 518-522.
29. Sloka S, Silva C, Wang J, Yong VW,. Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. J Neuroinflammation 2011; 8: 56.
30. Niyonsaba F, Ushio H, Hara M, Yokoi H, Tominaga M, Takamori K, et al. Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J Immunol 2010; 184: 3526-3534.
31. Muthian G, Raikwar HP, Rajasingh J, Bright JJ,. 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNγ axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res 2006; 83: 1299-1309.
32. Xu M, Morishima N, Mizoguchi I, Chiba Y, Fujita K, Kuroda M, et al. Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. Eur J Immunol 2011; 41: 2828-2839.